CD8A and Stroke: Clinically, robust infiltration of activated T cells into the infarct brain has been reported on day 140 after stroke, of which > 60% are CD3+ CD8+ T cells, suggesting a long-lasting T cell response in the human ischemic brain [101, 148, 150].